Pharmicell Non-Registered Director Seong Hyeon-sul Discloses Minor Share Change via Employee Stock Plan

Pharmicell non-registered director Seong Hyeon-sul acquired 668 common shares on June 16, 2026 through an employee stock ownership plan.
His total holdings increased from 978 to 1,646 shares, yet the ownership ratio remains negligible at 0.00% of total outstanding shares.
This filing represents a minor insider holding change with no material impact on the company's capital structure or shareholder value.
[AI Summary]The small-scale share acquisition by a non-registered director at Pharmicell is akin to a minor insider purchase with no market-moving implications. Investors need not adjust their positions as the event does not alter the stock price outlook or investment risk.